Columbia University

Technology Ventures

New York State Biodefense Commercialization Fund

Monday, October 4, 2021 - 5:00pm

Applications are now available for New York State’s new $40 million Biodefense Commercialization Fund that will provide grants of as much as $4 million to startups and academic research projects to help accelerate the development and commercialization of life science research that addresses serious infectious disease threats, including COVID-19 and its variants.

Eligible companies that are developing promising diagnostics, therapeutics, vaccines, and other innovations to prevent, treat or mitigate serious infectious disease threats may apply for grants of up to $4 million. New York’s academic research institutions will be able to apply for grants of up to $500,000 to help fast track advanced intellectual property that is on the cusp of moving to a commercial phase and university exit.  An emphasis will be placed on supporting the development of innovations with the highest potential for commercial viability.

To submit an application or learn more about the Fund, please visit the program’s website at, or email [email protected]